2020 Cloëtta Prize awarded to Basel breast cancer researcher Mohamed Bentires-Alj
This year’s Cloëtta Prize is awarded to researchers from Basel and Bern. Mohamed Bentires-Alj, Professor of Experimental Surgical Oncology at the University and University Hospital of Basel, and Nadia Mercader Huber, Professor in Anatomy, Developmental Biology and Regeneration at the University of Bern. They will each receive 50,000 Swiss francs.
19 October 2020
Prof. Dr. Mohamed Bentires-Alj, who is trained in pharmaceutical sciences, is being honored by the Cloëtta Foundation for his groundbreaking research in the field of breast cancer. His group at the Department of Biomedicine investigates the molecular and cellular causes of tumor heterogeneity and the consequences for metastasis formation and resistance to therapy. Together with clinicians, he has developed a breast cancer personalized treatment program. The results may pave the way for new therapies.
As the founder and president of the European Network for Breast Development and Cancer, Bentires-Alj fosters global interactions between labs worldwide, as the Foundation writes. As a co-founder of the Basel Breast Consortium, he is also committed to promoting local basic, clinical and translational interdisciplinary research projects.
Prof. Dr. Nadia Mercader Huber, Professor of Anatomy, Developmental Biology and Regeneration at the University of Bern, will also be honored for her outstanding research work; she investigates the cellular and molecular mechanisms of heart development and regeneration.
The ceremony for this year’s Cloëtta Prize will take place on 6 November 2020 in Bern. The prize is awarded annually to Swiss and foreign personalities who have rendered outstanding services to medical research.